Skip to main content

Personal Protective Equipment


We have an opportunity to improve the short term and long term approach to Personal Protective Equipment (PPE) worldwide. We can best meet this opportunity by respecting one another’s place and space.

We should:
  • Initiate international, regional and local discussions around PPE needs. Ask countries what the want and need, and set intentions for standardization with genuine partnership.
  • Catalog the regulatory agencies involved with PPE by country.
  • Detail the manufacturing supply chain by country. Detail the current processes, time and transport logistics. List and compare product safety processes involved, including failures and breaches noted. If 60% of the PPE manufacturing is based in two countries, what is the being asked of the rest of the world? What are populations awaiting, what are the logistics issues, what are the regulatory and product safety differences between countries and how are these populations affected? Are comparisons even offered before procurement? 
  • Develop surveillance and data around PPE use. Have countries’ product safety and regulatory differences mattered when examining healthcare-acquired or workplace transmission of COVID or other pathogens? Is the same HAI and/or workplace surveillance conducted in a country with multi-manufacturer use? 
  • Detail a research and development plan that is inclusive of LMIC at all stages of research.
  • Initiate a global plan to address the recommendations, with indicators and timelines structured to recent reports.
      
            1. The five main recommendations should be a global movement. They include: 

            

            *Assembling PPE innovation

            *Improving PPE standards and quality

            *Expanding PPE manufacturing capabilities

            *Strengthening procurement practices

            *Improving usage and disposal


    2. Five recommendations for sector focus on PPE improvements include: 


*Government. Government can support and steer the establishment of at-scale regional manufacturing, supplement national preparedness stocks of PPE, and move beyond lowest-price to encourage the development of high quality and innovative PPE. We should partner with governments when welcomed. 


*World Health. World health and WHO should add the key element of ‘access to PPE’ in preparedness frameworks. Regulators and standards organisations should be convened to harmonie medical PPE standards, and target product characteristics for PPE should be set for innovative design. World health can gently steer countries forward with preparedness in mind, emphasizing preparedness for each country. 


*Philanthropic and nonprofit funding. Funders should develop and enforce ‘pull’ and ‘push’ incentives for innovation by establishing visibility mechanisms for HCW in need and visibility on PPE innovation. Funders should take care to ask populations and countries what innovations are a fit, as well.


*Financial institutions. Development banks and finance institutions can support local manufacturing and testing capacity by financing solutions and guidance. Development banks should invest in PPE,  the development of national procurement processes, quality assurance mechanisms and last mile delivery systems. 
 
*Manufacturers. Manufacturers need to engage with governments, stakeholders, innovators that meet affordability, safety and quality for healthcare. 


Rather than reinvent the wheel, we can develop a strong PPE system with expertise already at the table. And, we can do so with vested country leadership. With healthcare first in mind, the structure of PPE improvements will be set for all industries requiring personal protection on the job. 


A solid, predictable, sustainable, science-based PPE system should be prioritized, and it should be prioritized when welcomed into a country’s place and space.

Comments

Post a Comment

Popular posts from this blog

Oxygen

Keeping it simple for oxygen coordination is best accomplished when we're welcomed in.  It’s good to support global leadership in medical oxygen supply management for underserved communities and countries in need.  It’s great to support efforts that strengthen individual country leadership toward national strategies on medical oxygen supply management.   Both require some tread into a country’s vulnerabilities on medical needs.  Let’s tread meaningfully and in a way that assures a welcome back.  Detail the coordinating agencies or government departments responsible for medical oxygen supply receipt. Meet with health administrators.  Detail a country’s current policies, compare with a global review and detail opportunities for policies on oxygen management. Is medical oxygen supply and/or maintenance an ongoing regulatory component within a country? What would it take to sharpen regulatory efforts? Is medical oxygen supply a component to ongoing emergen...
Post a Comment
Read more

Collaboration

A leadership presence at the table means little without mutual respect and a consistent, reliable, collaborative presence in one another’s space. Healthcare leadership does require influential action, not just parental correspondence or command.  As global health improves on leadership and collaboration in an increasingly small world, we can help balance global health work for maximum influence and leadership presence. *List and detail international health agencies, by charitable organization and governing status. Detail the duplication, reach and leadership. Involve agencies together, through liaisons. *Evaluate world health organization (WHO) and other agency credibility, respect and influence. Evaluate this by peer organization, interindustry organization and by country. Ask for survey creation and feedback assistance. Respect unbiased response.  * Dedicate a strategic plan to extend global health into national health and partner agency collaboration. Create action with urg...
Post a Comment
Read more

Responsiveness

Responsiveness in healthcare affects optimal management, psychological safety, physical safety, customer service and quality.  Responsiveness is often dropped, or not followed through, or placed as a one-time play.  When considering others’ places and spaces, healthcare must anticipate that the gaps left by “no reply” get filled in. One way or another, a lack of response gets substituted. Often, misinformation gets deputized. As healthcare becomes increasingly interested in “infodemics” [1] and misinformation, healthcare must first take responsibility and ownership of responsiveness.  In others places and spaces, and in healthcare’s own, there must be ownership of:    How often concerns are raised to the organization, and to global health, by experts in medical fields? In other fields? How often concerns are raised by general members of the public?  The types of concerns raised Potential algorithms or classifications, so that critical reviews can occur in a...
Post a Comment
Read more